Bifurcation Lesions Market Growth Accelerates: Strategic Forecast Predicts $4.02 Billion by 2029

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Will the Bifurcation Lesions Industry Market Size Be by 2025?
In recent times, the size of the market for bifurcation lesions has shown robust growth. It is projected to increase from $2.63 billion in 2024 to $2.86 billion in 2025, with a compound annual growth rate (CAGR) of 8.5%. The considerable growth in the historical phase has been due to the increasing incidents of coronary artery diseases, the growth in the elderly population, higher healthcare expenditure, and economic expansion.

What's the Long-Term Growth Forecast for the Bifurcation Lesions Market Size Through 2029?
The market for bifurcation lesions is slated to witness substantial growth in the forthcoming years, with the market size projected to reach $4.02 billion by 2029, premised on a compound annual growth rate (CAGR) of 8.9%. This surge in the predicted period can be associated with the escalating demand for less invasive surgical procedures, augmented healthcare structure and facilities, an upswing in rates of cardiovascular diseases, and government policies regarding healthcare. Key trends during the scheduled period incorporate patient-focused methods, bioresorbable stents, the implementation of artificial intelligence and machine learning, and cooperation across various specialties.

View the full report here:
https://www.thebusinessresearchcompany.com/report/bifurcation-lesions-global-market-report

What Are the Key Growth Drivers Fueling the Bifurcation Lesions Market Expansion?
The surge in the elderly population is anticipated to propel the advancement of the bifurcation lesions market. Individuals over the age of 60 have a greater risk of experiencing a heart attack, stroke, or succumbing to coronary heart disease and heart failure compared to their younger counterparts. In these instances, bifurcation lesions play a crucial role in treating blood clots to facilitate appropriate blood flow to the heart. A report by the World Health Organization, a Swiss institution tasked with overseeing global public health, disclosed in October 2022 that one out of six individuals is predicted to be 60 or older by 2030 worldwide. By 2050, the global population of individuals who are 60 or older will reach 2.1 billion. The population of individuals aged 80 or older will rise by 426 million from 2020 to 2050 in comparison to the current populace. Consequently, the escalating elderly population will spur the growth of the bifurcation lesions market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7414&type=smp

What Are the Key Trends Driving Bifurcation Lesions Market Growth?
The progression in imaging and procedure equipment signifies an emerging trend within the bifurcation lesions market. Leading companies within this market are placing a high emphasis on improving the devices currently utilized in imaging and procedures. For example, Advanced Bifurcation Systems (ABS), a medical device company presently in the clinical trial phase, offers an exclusive solution for bifurcation stenting to standardize the treatment of all bifurcation lesions in coronary angioplasties. Notably, the ABS platform showcases the only modular self-aligning stent technology that can adequately construct bifurcations. As a unique singular system, the ABS platform minimizes the necessity for additional procedures and facilitates an efficient bifurcation stenting treatment.

How Is the Bifurcation Lesions Market Segmented?
The bifurcation lesions market covered in this report is segmented -

1) By Types: One-Stent, Two-Stent
2) By Application: Coronary Vascular, Peripheral Vascular

Subsegments:
1) By One-Stent: Single-Stent Deployment, Balloon-Expandable Stents, Self-Expanding Stents
2) By Two-Stent: Crush Technique, T- or Y-Configuration Stenting, Side Branch Stenting Techniques

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7414&type=smp

Which Companies Are Leading the Charge in Bifurcation Lesions Market Innovation?
Major companies operating in the bifurcation lesions market include Boston Scientific Corporation, Terumo Medical Corporation, Spectranetics Corporation, Medtronic plc, Cardinal Health Inc., Cardinal Health Company, Abbott Laboratories, Biosensors International Group Ltd., B. Braun Melsungen AG, Cook Medical LLC, Cordis Corporation, Endologix Inc., W. L. Gore & Associates Inc., InspireMD Inc., MicroPort Scientific Corporation, OrbusNeich Medical Company Limited, Biotronik SE & Co. KG, Cardionovum GmbH, Elixir Medical Corporation, Medinol Ltd., Meril Life Sciences Pvt. Ltd., Opto Circuits (India) Ltd., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Svelte Medical Systems Inc., Translumina GmbH, Vascular Concepts Limited, Vascular Solutions Inc., Veryan Medical Ltd., X-Cell Medical Inc., Zorion Medical Inc., Amaranth Medical Inc., Cardiomind Inc., Cardiva Medical Inc.

Which Regions Are Leading the Global Bifurcation Lesions Market in Revenue?
North America was the largest region in the bifurcation lesions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bifurcation lesions market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7414

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.